BOAN BIOTECH (06955) has announced that Dr. Dou Changlin, an executive director, has reached the statutory retirement age and has voluntarily resigned from his positions as executive director, head of research and development, chief operating officer, and chairman of the strategic committee. Following his resignation, effective March 31, 2026, Dr. Dou will no longer hold any position within the company, its subsidiaries, or associated companies. Effective from the same date, Ms. Jiang Hua, the chairperson of the board and an executive director, will assume the role of chairman of the strategic committee. Additionally, Mr. Wang Shenghan, an executive director, will be appointed as a member of the strategic committee.